Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo

Gewirtz, 1998, Nucleic acid therapeutics, Blood, 92, 712, 10.1182/blood.V92.3.712 Ye, 1998, Targeted gene correction, Mol Med Today, 4, 431, 10.1016/S1357-4310(98)01344-6 Mohr, 1999, Targeted gene transfer to hepatocellular carcinoma cells in vitro using a novel monoclonal antibody-based gene delivery system, Hepatology, 29, 82, 10.1002/hep.510290148 Curiel, 1991, Adenovirus enhancement of transferrin–polylysine-mediated gene delivery, Proc Natl Acad Sci USA, 88, 8850, 10.1073/pnas.88.19.8850 Bilbao, 1998, Targeted adenoviral vectors for cancer gene therapy, Adv Exp Med Biol, 451, 365, 10.1007/978-1-4615-5357-1_57 Smith, 1998, Inhibition of tumorigenesis in a murine B-cell lymphoma transplant model by c-Myc complementary oligonucleotides, Adv Exp Med Biol, 451, 17, 10.1007/978-1-4615-5357-1_3 Nakamura, 1998, A comparison of in vivo gene delivery methods for antisense therapy in ligament healing, Gene Ther, 5, 1455, 10.1038/sj.gt.3300765 Pierce, 1998, Construction of a directed hammerhead ribozyme library, Nucleic Acids Res, 26, 5093, 10.1093/nar/26.22.5093 Crooke, 1998, An overview of progress in antisense therapeutics, Antisense Nucleic Acid Drug Dev, 8, 115, 10.1089/oli.1.1998.8.115 Stull, 1995, Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects, Pharm Res, 12, 465, 10.1023/A:1016281324761 Robbins, 1998, Viral vectors for gene therapy, Pharmacol Ther, 80, 35, 10.1016/S0163-7258(98)00020-5 Cristiano, 1998, Targeted, non-viral gene delivery for cancer gene therapy, Frontiers Biosci, 3, D1161, 10.2741/A352 Behr, 1993, Synthetic gene transfer vectors, Acc Chem Res, 26, 274, 10.1021/ar00029a008 Kukowska-Latallo, 1996, Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers, Proc Natl Acad Sci USA, 93, 4897, 10.1073/pnas.93.10.4897 Bielinska, 1996, Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using Starburst™ PAMAM dendrimers, Nucleic Acids Res, 24, 2176, 10.1093/nar/24.11.2176 Baker JR, Bielinska A, Johnson J, Yin R, Kukowska-Latallo JF. Efficient transfer of genetic material into mammalian cells using polyamidoamine dendrimers as synthetic vectors. In: Felgner PL, Heller MJ, Lehn P, Behr J-P, Szoka FC, editors. Artificial self-assembly systems for gene delivery. Washington DC: American Chemical Society, 1996. Haensler, 1993, Polyamidoamine cascade polymers mediate efficient transfection of cells in culture, Bioconjug Chem, 4, 372, 10.1021/bc00023a012 Tang, 1996, In vitro gene delivery by degraded polyamidoamine dendrimers, Bioconjug Chem, 7, 703, 10.1021/bc9600630 Tang, 1997, The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes, Gene Ther, 4, 823, 10.1038/sj.gt.3300454 Tomalia, 1990, Starburst dendrimers, Agnew Chem Int Ed Engl, 29, 138, 10.1002/anie.199001381 Frechet, 1994, Functional polymers and dendrimers, Science, 263, 1710, 10.1126/science.8134834 Roberts, 1996, Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers, J Biomed Mater Res, 30, 53, 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q Choate, 1997, Direct cutaneous gene delivery in a human genetic skin disease, Human Gene Ther, 8, 1659, 10.1089/hum.1997.8.14-1659 Trainer, 1997, Gene delivery to the epidermis, Human Mol Gen, 6, 1761, 10.1093/hmg/6.10.1761 Jain, 1998, Controlled drug delivery by biodegradable poly(ester) devices, Drug Dev Ind Pharm, 24, 703, 10.3109/03639049809082719 Luck, 1998, Plasma protein adsorption on biodegradable microspheres consisting of poly(d,l-lactide-co-glycolide), poly(l-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymercomposition, J Control Rel, 55, 107, 10.1016/S0168-3659(98)00030-3 Webber, 1998, Characterization of soluble, salt-loaded, degradable PLGA films and their release of tetracycline, J Biomed Mater Res, 41, 18, 10.1002/(SICI)1097-4636(199807)41:1<18::AID-JBM3>3.0.CO;2-T Garcia-Contreras, 1997, Biodegradable cisplatin microspheres for direct brain injection, Pharm Dev Technol, 2, 53, 10.3109/10837459709022609 Li, 1997, A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery, J Pharm Sci, 86, 891, 10.1021/js970084i Rao, 1997, Permeability studies of cellulose acetate free films for transdermal use, Pharm Acta Helv, 72, 47, 10.1016/S0031-6865(96)00060-X Friend, 1989, Transdermal delivery of levonorgestrel. Preparation of devices and evaluation in vitro, Pharma Res, 6, 938, 10.1023/A:1015937311711 Thacharodi, 1996, Rate-controlling biopolymer membranes as transdermal delivery systems for nifedipine, Biomaterials, 17, 1307, 10.1016/0142-9612(96)88676-5 Rao, 1995, Recent developments of collagen-based materials for medical applications and drug delivery systems, J Biomater Sci Polym Ed, 7, 623 Chang, 1984, Artificial cells in medicine and biotechnology, Appl Biochem Biotechnol, 10, 5, 10.1007/BF02783732 Giannos, 1997, Temporally controlled drug delivery systems, J Pharm Sci, 84, 539, 10.1002/jps.2600840505 Kalish, 1996, Sensitization of mice to topically applied drugs, Contact Dermatitis, 35, 76, 10.1111/j.1600-0536.1996.tb02294.x Prisant, 1992, Novel drug-delivery systems for hypertension, Am J Med, 93, 45S, 10.1016/0002-9343(92)90294-L Spieker, 1988, Transdermal beta-blocker therapy in essential hypertension, Am J Hypertension, 1, 199S, 10.1093/ajh/1.3.199S Page, 1998, Differentiation-specific enhancer activity in transduced keratinocytes, Gene Ther, 5, 394, 10.1038/sj.gt.3300591 Jane, 1998, Vector development, Annals of Medicine, 30, 413, 10.3109/07853899809002481 Niemiec, 1997, Perifollicular transgenic expression of human interleukin-1 antagonist protein following topical application of novel liposome—DNA formulations in vivo, J Pharm Sci, 86, 701, 10.1021/js9604873 Qin, 1998, Efficient transfer of genes into murine cardiac grafts by Starburst polyamidoamine dendrimers, Human Gene Ther, 9, 553, 10.1089/hum.1998.9.4-553 Wiener, 1994, Dendrimer-based metal ion chelates and their application to magnetic resonance imaging, Magn Reson Med, 31, 1, 10.1002/mrm.1910310102 Barth, 1994, Boronated Starburst dendrimer-monoclonal antibody immunoconjugates, Bioconj Chem, 5, 58, 10.1021/bc00025a008 Bielinska, 1997, The interactions of plasmid DNA with polyamidoamine dendrimers, Biochim Biophis Acta, 1353, 180, 10.1016/S0167-4781(97)00069-9 Yew, 1997, Optimization of plasmid vectors for high-level expression in lung epithelial cells, Human Gene Ther, 8, 575, 10.1089/hum.1997.8.5-575 Raczka, 1998, The effect of synthetic surfectant Exosurf on gene transfer in mouse lung in vivo, Gene Ther, 5, 1333, 10.1038/sj.gt.3300752 Baumann, 1998, Simultaneous visualization of the yellow and green forms of the green fluorescent protein in living cells, J Histochem Cytochem, 46, 1073, 10.1177/002215549804600911 Sambrook, 1994 Bielinska, 1999, DNA complexing with polyamidoamine dendrimers, Bioconj Chem, 10, 843, 10.1021/bc990036k